News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Angelia Jolie Surgery Pushes Myriad Genetics, Inc. (MYGN) Into Spotlight


5/15/2013 7:49:13 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Shares of diagnostic test maker Myriad Genetics Inc. rose to a three-year high Tuesday, as analysts said actions by the Supreme Court and actress Angelina Jolie could both help the company. THE SPARK: Oscar-winner Jolie disclosed Tuesday that she recently had a preventative double mastectomy after learning she faced a high risk of breast and ovarian cancer because of an inherited genetic mutation. Myriad makes a test called BRACAnalysis that looks for that mutation, and the test is the source of most of the company's revenue. On Monday the U.S. Supreme Court upheld Monsanto Co.'s claim that a farmer in Indiana violated one of its patents on soybean seeds. The patents covered genetic modification that made the seeds resistant to Monsanto's Roundup herbicide.

Help employers find you! Check out all the jobs and post your resume.



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES